Bridelia montana Willd.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Euphorbiaceae. |
| Habitat | The sub-Himalayan tract from Kashmir eastwards to Assam, and in Bihar, Orissa and Andhra Pradesh. |
| Ayurvedic | Ekaviraa. |
| Siddha / Tamil | Venge-maram. |
| Folk | Gondni, Asaanaa (Maharashtra). |
| Action | Bark and Root—astringent, anthelmintic. Used in the treatment of bone fracture. The root contains 5.7% tannins. |
| Taxonomic Cohort | Genus Bridelia (2 documented species); Family Euphorbiaceae (50 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Bridelia montana (taxonomically cited with authority Willd.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Euphorbiaceae (primary family classification: Euphorbiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The sub-Himalayan tract from Kashmir eastwards to Assam, and in Bihar, Orissa and Andhra Pradesh.
Across classical and vernacular Indian systems of medicine, Bridelia montana is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Ekaviraa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Venge-maram; in regional Indian folk and vernacular ethnobotany as Gondni, Asaanaa (Maharashtra). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bridelia montana are: Bark and Root—astringent, anthelmintic. Used in the treatment of bone fracture. The root contains 5.7% tannins. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bridelia montana establish the following evidence base: The leaves contain beta-sitosterol, its beta-D-glucoside and a triterpenoid. Fructose, glucose and sucrose were identified as the components of the glycoside.

Botanical Reference 1: Bridelia montana — Wikimedia Commons

Botanical Reference 2: Bridelia montana — Wikimedia Commons

Botanical Reference 3: Bridelia montana — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Bridelia comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Bridelia retusa (Action: Bark—astringent, used in the form of a liniment in rheumatism. Paste of the stem…). Comparing Bridelia montana alongside its congeners in genus Bridelia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Euphorbiaceae encompasses 50 documented medicinal species (2.76% of the 1,814-species flora). Other representative medicinal members of Euphorbiaceae include: Acalypha ciliata (Kuppi), Acalypha fruticosa (Birch-leaved Acalypha), Acalypha indica (Kuppi), Aleurities moluccana (Akshota), Baliospermum montanum (Danti). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 50 medicinal species of family Euphorbiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Bridelia montana follow the plant-part modalities specified under its therapeutic action (Bark and Root—astringent, anthelmintic. Used in the treatment of bone fracture. The root contains 5.7% tannins), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Bridelia montana integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.